3/30
02:27 pm
alpmy
IRWD Stock Down 14% in a Month: Time to Buy, Sell or Hold the Stock? [Yahoo! Finance]
Low
Report
IRWD Stock Down 14% in a Month: Time to Buy, Sell or Hold the Stock? [Yahoo! Finance]
3/26
05:49 am
alpmy
Astellas Pharma (ALPMY) was upgraded by Jefferies Financial Group Inc. from "hold" to "strong-buy".
Low
Report
Astellas Pharma (ALPMY) was upgraded by Jefferies Financial Group Inc. from "hold" to "strong-buy".
3/18
08:12 am
alpmy
IsomAb appoints Dr Philip Brainin as Chief Executive Officer [Yahoo! Finance]
Low
Report
IsomAb appoints Dr Philip Brainin as Chief Executive Officer [Yahoo! Finance]
3/16
01:25 pm
alpmy
JAMP Pharma Group Expands Oncology Portfolio with PrJAMP Enzalutamide [Yahoo! Finance]
Low
Report
JAMP Pharma Group Expands Oncology Portfolio with PrJAMP Enzalutamide [Yahoo! Finance]
3/10
08:46 am
alpmy
BioNTech's Founding Duo Will Leave to Start New mRNA Firm [Yahoo! Finance Canada]
Low
Report
BioNTech's Founding Duo Will Leave to Start New mRNA Firm [Yahoo! Finance Canada]
3/10
08:42 am
alpmy
BioNTech's Founding Duo Will Leave to Start New mRNA Firm [Yahoo! Finance]
Low
Report
BioNTech's Founding Duo Will Leave to Start New mRNA Firm [Yahoo! Finance]
3/6
09:47 am
alpmy
Will Linzess Continue to Aid IRWD's Top Line in 2026 After a Soft Q4? [Yahoo! Finance]
Low
Report
Will Linzess Continue to Aid IRWD's Top Line in 2026 After a Soft Q4? [Yahoo! Finance]
2/23
05:48 pm
alpmy
Vir surges on up to $1.7B deal with Astellas to advance prostate cancer asset [Seeking Alpha]
Low
Report
Vir surges on up to $1.7B deal with Astellas to advance prostate cancer asset [Seeking Alpha]
2/9
10:24 pm
alpmy
India's Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US [Yahoo! Finance]
Low
Report
India's Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US [Yahoo! Finance]
1/22
07:48 am
alpmy
Astellas Pharma (OTCMKTS:ALPMY) was downgraded by analysts at Citigroup Inc. from a "strong-buy" rating to a "hold" rating.
Low
Report
Astellas Pharma (OTCMKTS:ALPMY) was downgraded by analysts at Citigroup Inc. from a "strong-buy" rating to a "hold" rating.